A Prospective, Multicentric, Observational Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life RA Patients Treated With Abatacept SC
Latest Information Update: 20 Jun 2023
Price :
$35 *
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TIGHT
- Sponsors Bristol-Myers Squibb
- 15 Jun 2023 Status changed from active, no longer recruiting to completed.
- 04 Jan 2022 Planned End Date changed from 4 Aug 2021 to 1 Aug 2022.
- 04 Jan 2022 Planned primary completion date changed from 4 Aug 2019 to 1 Aug 2022.